Oncocyte to Announce Third Quarter 2023 Financial Results
November 03 2023 - 7:30AM
Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics
company, announced today that the company will host a conference
call and webcast on Thursday, November 9, 2023, at 5:00 a.m.
Pacific Time / 8:00 a.m. Eastern Time to discuss its third quarter
financial results and recent highlights. The third quarter 2023
financial results press release will be issued the same day,
approximately one hour before the conference call.
Interested parties may access the live call via
telephone by dialing toll free (888) 550-5422 for both domestic and
international callers. Once dialed in ask to be joined to the
Oncocyte Corporation call.
The live webcast of the call may be accessed by
visiting the “Events & Presentations” section of the Company’s
website at https://investors.oncocyte.com. A replay of the webcast
will be available on the Company’s website shortly after the
conclusion of the call.
About Oncocyte
Oncocyte is a precision diagnostics company. The
Company’s tests are designed to help provide clarity and confidence
to physicians and their patients. VitaGraft™ is a blood-based solid
organ transplantation monitoring test, DetermaIO™ is a gene
expression test that assesses the tumor microenvironment to predict
response to immunotherapies. and the pipeline test DetermaCNI™ is
blood-based monitoring tool for monitoring therapeutic efficacy in
cancer patients. For more information, visit
https://oncocyte.com/
VitaGraft™, DetermaIO™, and DetermaCNI™ are
trademarks of Oncocyte Corporation.
Contact:
Stephanie PrincePCG Advisory(646)
863-6341sprince@pcgadvisory.com
Oncocyte (NASDAQ:OCX)
Historical Stock Chart
From Apr 2024 to May 2024
Oncocyte (NASDAQ:OCX)
Historical Stock Chart
From May 2023 to May 2024